This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAMIN 15 MG TAB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2370 per EA under NDC 00555077702. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Feb 11, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 15 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555077702
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040422FDA Approved
2/11/2002
TE Code
AB
On Market Since
3/19/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2370 per EA |
|---|---|
| All-time high | $1.1626 (Oct 15, 2014) |
| All-time low | $0.1838 (Nov 20, 2024) |
| 52-week high | $0.2936 |
| 52-week low | $0.2370 |
| Median price | $0.3676 |
| Average price | $0.4668 |
| Largest weekly change | +39.5% (Feb 22, 2023) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 15 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 15 MG TAB, manufactured by Teva Pharmaceuticals USA Inc., is $0.2370 per EA (NDC 00555077702), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 15 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has declined 75.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 15 MG TAB?
Since Nov 28, 2013, the NADAC for DEXTROAMP-AMPHETAMIN 15 MG TAB has ranged from a low of $0.1838 (Nov 20, 2024) to a high of $1.1626 (Oct 15, 2014), with a median of $0.3676 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 15 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHETAMIN 15 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHETAMIN 15 MG TAB?
DEXTROAMP-AMPHETAMIN 15 MG TAB (NDC 00555077702) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 15 MG TAB in shortage?
Yes — NDC 00555077702 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).